1. Integrating Genomic Alterations in Diffuse Large B-Cell Lymphoma Identifies New Relevant Pathways and Potential Therapeutic Targets
- Author
-
Dlouhy, Ivan, Karube, Kennosuke, Enjuanes, Anna, Martín-García, David, Nadeu, Ferran, Ordoñez, Gonzalo R, Rovira, Jordina, Royo, Cristina, Navarro, Alba, Gonzalez, Blanca, Castellano, Giancarlo, Rubio-Perez, Carlota, Tamborero, David, Briones, Javier, Salar, Antonio, Sancho, Juan-Manuel, Mercadal, Santiago, Gonzalez Barca, Eva, Escoda, Lourdes, Hiroaki, Miyoshi, Ohshima, Koichi, Kato, Koji, Akashi, Koichi, Mozos, Anna, Colomo, Lluis, Alcoceba, Miguel, Valera, Alexandra, Carrio, Anna, Lopez-Bigas, Nuria, Schmitz, Roland, Staudt, Louis, Jares, Pedro, Salaverria, Itziar, López-Guillermo, Armando, and Campo, Elias
- Abstract
Sancho: Celltrion, Inc: Research Funding; Gilead: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Sanofi: Membership on an entity's Board of Directors or advisory committees; Janssen: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Roche: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau. Gonzalez Barca:Janssen: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Roche: Speakers Bureau; Gilead: Speakers Bureau. Ohshima:Kyowa Hakko Kirin Co., Ltd.: Research Funding, Speakers Bureau; CHUGAI PHARMACEUTICAL CO.,LTD.: Research Funding, Speakers Bureau. Akashi:Sunitomo Dainippon Pharma: Consultancy; Celgene: Research Funding; Kyowa Hakko Kirin: Consultancy, Research Funding; Bristol Meyers Squibb: Research Funding; Asahi Kasei Pharma Corporation: Research Funding; Chugai Pharmaceutical Co., Ltd.: Research Funding; Shionogi & Co., Ltd: Research Funding; Astellas Pharma: Research Funding.
- Published
- 2016
- Full Text
- View/download PDF